Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells

Stem Cells

Volumn 30, Issue 5, 2012, Pages 997-1007

  Lee, Seung Bum ^a   Seo, Daekwan ^a   Choi, Dongho ^a,c   Park, Kye Yoon ^b   Holczbauer, Agnes ^a   Marquardt, Jens U ^a   Conner, Elizabeth A ^a   Factor, Valentina M ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c Soonchunhyang University   (South Korea)

Author keywords

Donor memory; Hepatic differentiation; Hepatocyte lineage cells; Induced pluripotent stem cells

Indexed keywords

KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FIBROBLAST; LIVER CELL; MORPHOLOGY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; TERATOMA; UPREGULATION;

ANIMALS; CELL DEDIFFERENTIATION; HEK293 CELLS; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; LIVER; MICE; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 84860530018     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1074     Document Type: Article

References (55)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
2. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
3. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008;321: 699-702.
4. Liu H, Ye Z, Kim Y et al. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010;51:1810-1819.
5. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 2010;143:508-525.
6. Park IH, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886.
7. Ghodsizadeh A, Taei A, Totonchi M et al. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev 2010;6: 622-632.
8. Marchetto MC, Carromeu C, Acab A et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010;143:527-539.
9. Doi A, Park IH, Wen B et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
10. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
11. Pick M, Stelzer Y, Bar-Nur O et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-2690.
12. Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-531.
13. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471:68-73.
14. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010;107: 4335-4340.
15. Feng Q, Lu SJ, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010;28:704-712.
16. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28:848-855.
17. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-290.
18. Ohi Y, Qin H, Hong C et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011;13:541-549.
19. Bar-Nur O, Russ HA, Efrat S et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 2011; 9:17-23.
20. Zaret KS. Regulatory phases of early liver development: Paradigms of organogenesis. Nat Rev Genet 2002;3:499-512. (Pubitemid 34746875)
21. Si-Tayeb K, Lemaigre FP, Duncan SA. Organogenesis and development of the liver. Dev Cell 2010;18:175-189.
22. Nitou M, Sugiyama Y, Ishikawa K et al. Purification of fetal mouse hepatoblasts by magnetic beads coated with monoclonal anti-E-cadherin antibodies and their in vitro culture. Exp Cell Res 2002;279: 330-343. (Pubitemid 35217561)
23. Gai H, Nguyen DM, Moon YJ et al. Generation of murine hepatic lineage cells from induced pluripotent stem cells. Differentiation 2010; 79:171-181.
24. Si-Tayeb K, Noto FK, Nagaoka M et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010;51:297-305.
25. Heo J, Factor VM, Uren T et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 2006;44:1478-1486. (Pubitemid 44953653)
26. Dhawan A, Puppi J, Hughes RD et al. Human hepatocyte transplantation: Current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010;7:288-298.
27. Ochiya T, Yamamoto Y, Banas A. Commitment of stem cells into functional hepatocytes. Differentiation 2010;79:65-73.
28. Kao CY, Factor VM, Thorgeirsson SS. Reduced growth capacity of hepatocytes from c-Myc and c-Myc/TGF-alpha transgenic mice in primary culture. Biochem Biophys Res Commun 1996;222: 64-70. (Pubitemid 26152206)
29. Conner DA. Mouse embryo fibroblast (MEF) feeder cell preparation. Curr Protoc Mol Biol 2001; Chapter 23:Unit 23.2.
30. Morrison GM, Oikonomopoulou I, Migueles RP et al. Anterior definitive endoderm from ESCs reveals a role for FGF signaling. Cell Stem Cell 2008;3:402-415.
31. Sato N, Meijer L, Skaltsounis L et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004;10:55-63. (Pubitemid 38524699)
32. Jones EA, Clement-Jones M, James OF et al. Differences between human and mouse alpha-fetoprotein expression during early development. J Anat 2001;198:555-559. (Pubitemid 32519980)
33. Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 2000;14: 464-474. (Pubitemid 30131891)
34. Shao L, Feng W, Sun Y et al. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 2009;19:296-306.
35. Stadtfeld M, Hochedlinger K. Induced pluripotency: History, mechanisms, and applications. Genes Dev 2010;24:2239-2263.
36. Kamiya A, Kinoshita T, Ito Y et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 1999;18:2127-2136. (Pubitemid 29179170)
37. Duncan SA, Watt AJ. BMPs on the road to hepatogenesis. Genes Dev 2001;15:1879-1884. (Pubitemid 32738618)
38. Hirabayashi Y, Sekiguchi T et al. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 2003;102: 3154-3162. (Pubitemid 37314751)
39. Rossi JM, Dunn NR, Hogan BL et al. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001;15:1998-2009. (Pubitemid 32738628)
40. Marchetto MC, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009;4:e7076.
41. Ghosh Z, Wilson KD, Wu Y et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 2010;5:e8975.
42. Barrero MJ, Izpisua Belmonte JC. iPS cells forgive but do not forget. Nat Cell Biol 2011;13:523-525.
43. Kadam S, Emerson BM. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 2003;11:377-389. (Pubitemid 36293832)
44. Inayoshi Y, Miyake K, Machida Y et al. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development. J Biochem 2006;139: 177-188.
45. Gresh L, Bourachot B, Reimann A et al. The SWI/SNF chromatin-emodeling complex subunit SNF5 is essential for hepatocyte differentiation. EMBO J 2005;24:3313-3324. (Pubitemid 41348705)
46. Gao X, Tate P, Hu P et al. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc Natl Acad Sci USA 2008;105:6656-6661. (Pubitemid 351754562)
47. Wu L, Aster JC, Blacklow SC et al. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 2000;26:484-489.
48. Poirault-Chassac S, Six E, Catelain C et al. Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation. Blood 2010; 116:5670-5678.
49. Ishiko E, Matsumura I, Ezoe S et al. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem 2005;280:4929-4939. (Pubitemid 40288668)
50. Hald J, Hjorth JP, German MS et al. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev Biol 2003;260:426-437. (Pubitemid 36966084)
51. Ma X, Renda MJ, Wang L et al. Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. Mol Cell Biol 2007;27:3056-3064. (Pubitemid 46581318)
52. Shi L, Perin JC, Leipzig J et al. Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene 2011; 487:21-28.
53. Douglas J, Cilliers D, Coleman K et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet 2007;39:963-965.
54. Mikkelsen TS, Hanna J, Zhang X et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454: 49-55. (Pubitemid 351931978)
55. Deng J, Shoemaker R, Xie B et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009;27:353-360.